Target intelligence / Profile preview

Toxic soluble amyloid oligomer (α-sheet conformation)

Molecular classification
Protein aggregate, Oligomer
01

Overview

Toxic soluble amyloid oligomers adopting an α–sheet conformation represent a structurally distinct class of pathogenic aggregates central to neurodegenerative disease mechanisms. These small, non-fibrillar aggregates of amyloidogenic proteins form early in amyloidosis and are highly toxic, strongly implicated as the primary pathogenic species in diseases like Alzheimer's. The α-sheet is a distinct protein secondary structure featuring alternating backbone dihedral angles, resulting in an extended sheet-like arrangement with unique hydrogen bonding patterns. Targeting this α-sheet conformation with de novo designed peptides offers a promising strategy for broad-spectrum inhibition across different amyloid diseases.

Other names
Amyloid oligomers (α-sheet conformation)α-sheet amyloid oligomersToxic amyloid oligomersSoluble amyloid oligomers
02

Mechanism of action

Inhibition of aggregation, neutralization of toxicity

03

Biological functions

Induction of cell deathDisruption of synaptic functionProtein aggregation
04

Disease associations

Alzheimer’s diseaseNeurodegenerative diseaseProtein misfolding disorders
05

Safety considerations

Potential off-target effects of designed peptidesDelivery challenges to the brain
06

Interacting drugs

De novo designed peptides adopting complementary α-sheet conformations

Beyond the preview

Go deeper on Toxic soluble amyloid oligomer (α-sheet conformation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxic soluble amyloid oligomer (α-sheet conformation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call